Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Altamira Therapeutics Ltd. - Common Shares (NQ: CYTO ) 0.3001 UNCHANGED Last Price Updated: 3:55 PM EST, Dec 19, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 0.3001 Bid (Size) 0.2800 (2) Ask (Size) 0.2870 (58) Prev. Close 0.3001 Today's Range 0.3001 - 0.3001 52wk Range 0.3001 - 3.600 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Altamira Therapeutics Announces Transition from NASDAQ to OTC Markets December 20, 2024 From Altamira Therapeutics Ltd Via GlobeNewswire 12 Health Care Stocks Moving In Wednesday's Pre-Market Session November 06, 2024 Via Benzinga Performance YTD -91.33% -91.33% 1 Month -29.50% -29.50% 3 Month -55.21% -55.21% 6 Month -72.96% -72.96% 1 Year -88.97% -88.97% More News Read More Altamira Therapeutics Provides Update on Nasdaq Listing October 04, 2024 From Altamira Therapeutics Ltd Via GlobeNewswire Altamira Therapeutics Announces Extended ISO 13485 Quality Management System Certification for Bentrio Nasal Spray September 27, 2024 From Altamira Therapeutics Ltd Via GlobeNewswire Altamira Therapeutics Provides Business Update and First Half 2024 Financial Results September 24, 2024 From Altamira Therapeutics Ltd Via GlobeNewswire Altamira Therapeutics to Host First Half 2024 Financial Results and Business Update Call on September 24, 2024 September 20, 2024 From Altamira Therapeutics Ltd Via GlobeNewswire Altamira Therapeutics Announces Closing of up to $12.0 Million Public Offering September 19, 2024 From Altamira Therapeutics Ltd Via GlobeNewswire Altamira Therapeutics Announces Pricing of up to $12.0 Million Public Offering September 17, 2024 From Altamira Therapeutics Ltd Via GlobeNewswire Altamira Therapeutics Announces Expansion of Bentrio License and Distribution Agreement with Nuance Pharma in East and South East Asia September 16, 2024 From Altamira Therapeutics Ltd Via GlobeNewswire Altamira Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference September 9-11 September 03, 2024 From Altamira Therapeutics Ltd Via GlobeNewswire Altamira Therapeutics Announces Extension of Bentrio Distribution Agreement with Pharma Nordic to Include Sweden and Denmark August 23, 2024 From Altamira Therapeutics Ltd Via GlobeNewswire Altamira Therapeutics Announces Confirmed Suitability of Bentrio for Athletes as Comprehensive Testing Shows Absence of Prohibited Substances August 16, 2024 From Altamira Therapeutics Ltd Via GlobeNewswire Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday August 15, 2024 Via InvestorPlace Why Lumentum Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket August 15, 2024 Via Benzinga Altamira Therapeutics Announces Significant Enhancement of Immune Checkpoint Inhibition Therapy in Combination with Zbtb46 mRNA Delivered with SemaPhore Nanoparticles in Animal Tumor Models August 12, 2024 From Altamira Therapeutics Ltd Via GlobeNewswire Altamira Therapeutics Announces Publication of Preclinical Data Showing Successful Treatment of Abdominal Aortic Aneurysm with SOD2 mRNA Delivered by SemaPhore Nanoparticles July 19, 2024 From Altamira Therapeutics Ltd Via GlobeNewswire Altamira Therapeutics Highlights Newly Published Review Article Supporting Use of Betahistine in Vertigo Management June 20, 2024 From Altamira Therapeutics Ltd Via GlobeNewswire Altamira Therapeutics Provides Business Update May 28, 2024 From Altamira Therapeutics Ltd Via GlobeNewswire Hunting For Gains In Penny Stocks May 26, 2024 Via Talk Markets Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7.4 Billion By 2032 May 24, 2024 Via FinancialNewsMedia Topics Death Exposures Death 12 Health Care Stocks Moving In Thursday's Intraday Session May 23, 2024 Via Benzinga Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7.4 Billion By 2032 May 24, 2024 From FN Media Group LLC Via GlobeNewswire What's Going On With Altamira Therapeutics Stock? May 23, 2024 Via Benzinga Altamira Therapeutics Announces Dissemination of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis Through Social Media Channels of Top Allergy Journal May 23, 2024 From Altamira Therapeutics Ltd Via GlobeNewswire Altamira Therapeutics Announces Filing of Provisional Patent Application for OligoPhore Nanoparticles with siRNA Targeting p65 Protein in Treatment of Cancer and Inflammation May 01, 2024 From Altamira Therapeutics Ltd Via GlobeNewswire Stock Quote API & Stock News API supplied by www.cloudquote.io Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
